Skip to main content
TipRanks
Go Ultimate75% OFF

Niagen Bioscience (OCD1) Q3 2018 Earnings Report

2 Followers

DE:OCD1 Q3 2018 EPS Results

Actual EPS
-EUR 0.14
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.06

DE:OCD1 Q3 2018 Revenue Results

Actual Revenue
EUR 7.27M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2018
Date
11/07/2018
Time
After Close
Conference Call
Wednesday, November 7, 2018
DE:OCD1 Upcoming Earnings

Niagen Bioscience's next earnings date is estimated for March 10, 2027, based on past reporting schedules.

Q3 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:OCD1 Earnings History

DE:OCD1 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 10, 20272026 (Q4)-0.02-0.04――
Nov 04, 20262026 (Q3)-0.01-0.010.04-120.00% (-0.05)
Aug 04, 20262026 (Q2)0.010.010.04-75.00% (-0.03)
May 06, 20262026 (Q1)0.060.060.0516.67% (+0.01)
Mar 04, 20262025 (Q4)0.020.040.08-44.44% (-0.04)
Nov 04, 20252025 (Q3)0.020.040.0372.41% (+0.02)
Aug 06, 20252025 (Q2)0.010.040―
May 07, 20252025 (Q1)0.020.05-0.01700.00% (+0.06)
Mar 04, 20252024 (Q4)0.020.080―
Oct 31, 20242024 (Q3)0.010.030480.00% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed